相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prostate-Specific Membrane Antigen-Targeted Turn-on Probe for Imaging Cargo Release in Prostate Cancer Cells
Feyisola P. Olatunji et al.
BIOCONJUGATE CHEMISTRY (2021)
Small Molecule-Based Prodrug Targeting Prostate Specific Membrane Antigen for the Treatment of Prostate Cancer
Xinning Wang et al.
CANCERS (2021)
A prostate-specific membrane antigen (PSMA)-targeted prodrug with a favorable in vivo toxicity profile
Srikanth Boinapally et al.
SCIENTIFIC REPORTS (2021)
Preclinical Characterization of the Distribution, Catabolism, and Elimination of a Polatuzumab Vedotin-Piiq (POLIVY®) Antibody-Drug Conjugate in Sprague Dawley Rats
Victor Yip et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Whole-Body Pharmacokinetics and Physiologically Based Pharmacokinetic Model for Monomethyl Auristatin E (MMAE)
Hsuan Ping Chang et al.
JOURNAL OF CLINICAL MEDICINE (2021)
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer
Oliver Sartor et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Small molecule drug conjugates (SMDCs): an emerging strategy for anticancer drug design and discovery
Tarun Kumar Patel et al.
NEW JOURNAL OF CHEMISTRY (2021)
Long-Term Follow-up and Outcomes of Retreatment in an Expanded 50-Patient Single-Center Phase II Prospective Trial of 177Lu-PSMA-617 Theranostics in Metastatic Castration-Resistant Prostate Cancer
John Violet et al.
JOURNAL OF NUCLEAR MEDICINE (2020)
Antibody–Drug Conjugate Payloads; Study of Auristatin Derivatives
Michinori Akaiwa et al.
CHEMICAL & PHARMACEUTICAL BULLETIN (2020)
Pharmacotherapeutic strategies for castrate-resistant prostate cancer
Mohamad Moussa et al.
EXPERT OPINION ON PHARMACOTHERAPY (2020)
Intermittent versus continuous androgen deprivation therapy for advanced prostate cancer
Marlon Perera et al.
NATURE REVIEWS UROLOGY (2020)
Development of 5D3-DM1: A Novel Anti-Prostate-Specific Membrane Antigen Antibody-Drug Conjugate for PSMA-Positive Prostate Cancer Therapy
Colin T. Huang et al.
MOLECULAR PHARMACEUTICS (2020)
A click-ready pH-triggered phosphoramidate-based linker for controlled release of monomethyl auristatin E
Feyisola P. Olatunji et al.
TETRAHEDRON LETTERS (2020)
Surgical management of high-risk, localized prostate cancer
Lamont J. Wilkins et al.
NATURE REVIEWS UROLOGY (2020)
Trastuzumab-monomethyl auristatin E conjugate exhibits potent cytotoxic activity in vitro against HER2-positive human breast cancer
Meghdad Abdollahpour-Alitappeh et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Small molecule-drug conjugates: A novel strategy for cancer-targeted treatment
Chunlin Zhuang et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Phase I Study of CTT1057, an 18F-Labeled Imaging Agent with Phosphoramidate Core Targeting Prostate-Specific Membrane Antigen in Prostate Cancer
Spencer C. Behr et al.
JOURNAL OF NUCLEAR MEDICINE (2019)
Phase 1 study of PSMA ADC, an antibody-drug conjugate targeting prostate-specific membrane antigen, in chemotherapy-refractory prostate cancer
Daniel P. Petrylak et al.
PROSTATE (2019)
The effect of ligand amount, affinity and internalization on PSMA-targeted imaging and therapy: A simulation study using a PBPK model
Nusrat J. Begum et al.
SCIENTIFIC REPORTS (2019)
Cleavable linkers in antibody-drug conjugates
Jonathan D. Bargh et al.
CHEMICAL SOCIETY REVIEWS (2019)
Fate of Antibody-Drug Conjugates in Cancer Cells
Cecile Chalouni et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2018)
Glutamic acid-valine-citrulline linkers ensure stability and efficacy of antibody-drug conjugates in mice
Yasuaki Anami et al.
NATURE COMMUNICATIONS (2018)
Antitumor Activity of MEDI3726 (ADCT-401), a Pyrrolobenzodiazepine Antibody-Drug Conjugate Targeting PSMA, in Preclinical Models of Prostate Cancer
Song Cho et al.
MOLECULAR CANCER THERAPEUTICS (2018)
Strategies and challenges for the next generation of antibody drug conjugates
Alain Beck et al.
NATURE REVIEWS DRUG DISCOVERY (2017)
177Lu-Labeled Phosphoramidate-Based PSMA Inhibitors: The Effect of an Albumin Binder on Biodistribution and Therapeutic Efficacy in Prostate Tumor-Bearing Mice
Cindy J. Choy et al.
THERANOSTICS (2017)
Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma
Lesley J. Scott
DRUGS (2017)
Simple bioconjugate chemistry serves great clinical advances: albumin as a versatile platform for diagnosis and precision therapy
Zhibo Liu et al.
CHEMICAL SOCIETY REVIEWS (2016)
Structure-Activity Relationship of 18F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer
Shorouk Dannoon et al.
JOURNAL OF MEDICINAL CHEMISTRY (2016)
Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer
Steven P. Rowe et al.
JOURNAL OF NUCLEAR MEDICINE (2016)
Molecular Basis of Valine-Citrulline-PABC Linker Instability in Site-Specific ADCs and Its Mitigation by Linker Design
Magdalena Dorywalska et al.
MOLECULAR CANCER THERAPEUTICS (2016)
Impact of body composition parameters on clinical outcomes in patients with metastatic castrate-resistant prostate cancer treated with docetaxel
Samantha J. Cushen et al.
CLINICAL NUTRITION ESPEN (2016)
Antibody-Drug Conjugates and Small Molecule-Drug Conjugates: Opportunities and Challenges for the Development of Selective Anticancer Cytotoxic Agents
Giulio Casi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2015)
Internalization, Trafficking, Intracellular Processing and Actions of Antibody-Drug Conjugates
Shi Xu
PHARMACEUTICAL RESEARCH (2015)
A Small-Molecule Drug Conjugate for the Treatment of Carbonic Anhydrase IX Expressing Tumors
Nikolaus Krall et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2014)
Small Targeted Cytotoxics: Current State and Promises from DNA-Encoded Chemical Libraries
Nikolaus Krall et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2013)
DOTA Conjugate with an Albumin-Binding Entity Enables the First Folic Acid-Targeted Lu-177-Radionuclide Tumor Therapy in Mice
Cristina Mueller et al.
JOURNAL OF NUCLEAR MEDICINE (2013)
Engineering Folate-Drug Conjugates to Target Cancer: From Chemistry to Clinic
Iontcho R. Vlahov et al.
BIOCONJUGATE CHEMISTRY (2012)
Cabazitaxel: More Than a New Taxane for Metastatic Castrate-Resistant Prostate Cancer?
Alain C. Mita et al.
CLINICAL CANCER RESEARCH (2012)
Overcoming Drug Resistance and Treating Advanced Prostate Cancer
Julius Semenas et al.
CURRENT DRUG TARGETS (2012)
In Vitro and In Vivo Responses of Advanced Prostate Tumors to PSMA ADC, an Auristatin-Conjugated Antibody to Prostate-Specific Membrane Antigen
Xinning Wang et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Heterogeneity of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Carcinoma with Distant Metastasis
Sebastian Mannweiler et al.
PATHOLOGY & ONCOLOGY RESEARCH (2009)
Endocytic mechanisms for targeted drug delivery
Lisa A. Bareford et al.
ADVANCED DRUG DELIVERY REVIEWS (2007)
Development of potent monoclonal antibody auristatin conjugates for cancer therapy
SO Doronina et al.
NATURE BIOTECHNOLOGY (2003)
分享论文
